These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10693934)

  • 1. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1.
    Teixeira A; Chaverot N; Strosberg AD; Cazaubon S
    J Neurochem; 2000 Mar; 74(3):1034-40. PubMed ID: 10693934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase mediates endothelin-induced cyclin D3 expression in rat cultured astrocytes.
    Koyama Y; Yoshioka Y; Shinde M; Matsuda T; Baba A
    J Neurochem; 2004 Aug; 90(4):904-12. PubMed ID: 15287896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of cyclins D1 and D3 after inhibition of gap junctional communication in astrocytes.
    Tabernero A; Sánchez-Alvarez R; Medina JM
    J Neurochem; 2006 Feb; 96(4):973-82. PubMed ID: 16412096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells.
    Paternot S; Arsenijevic T; Coulonval K; Bockstaele L; Dumont JE; Roger PP
    Cell Cycle; 2006 Jan; 5(1):61-70. PubMed ID: 16294008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
    Paternot S; Dumont JE; Roger PP
    Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
    Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density dependent modulation of cell cycle protein expression in astrocytes.
    Nakatsuji Y; Miller RH
    J Neurosci Res; 2001 Nov; 66(3):487-96. PubMed ID: 11746367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
    Whittaker SR; Walton MI; Garrett MD; Workman P
    Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration.
    Morisset J; Aliaga JC; Calvo EL; Bourassa J; Rivard N
    Am J Physiol; 1999 Nov; 277(5):G953-9. PubMed ID: 10564100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice.
    Hampl A; Pacherník J; Dvorák P
    Biol Reprod; 2000 May; 62(5):1393-401. PubMed ID: 10775192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation: a key to its antiangiogenic action?
    Pai R; Szabo IL; Kawanaka H; Soreghan BA; Jones MK; Tarnawski AS
    Mol Cell Biol Res Commun; 2000 Aug; 4(2):111-6. PubMed ID: 11170841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.